QR Kodea

Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot randomized controlled trial

Abstract Background Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHEN...

Deskribapen osoa

Gorde:
Egile Nagusiak: Niall Filewod, Stephen Hwang, Christian J. Turner, Leena Rizvi, Sara Gray, Michelle Klaiman, Danielle Buell, Johnathan Ailon, Alexander Caudarella, Galo F. Ginocchio, Marlene Santos, Gyan Sandhu, Norman Dewhurst, Kelly Sequeira, Karen E. A. Burns
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2022-01-01
Saila:Pilot and Feasibility Studies
Gaiak:
Phenobarbital; Alcohol withdrawal
Delirium tremens
Treatment
Sarrera elektronikoa:https://doi.org/10.1186/s40814-021-00963-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak